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Abstract
Background: The protein kinase CK2 sustains multiple pro-survival functions in cellular DNA damage response and
its level is tightly regulated in normal cells but elevated in cancers. Because CK2 is thus considered as potential
therapeutic target, DNA double-strand break (DSB) formation and rejoining, apoptosis induction and clonogenic
survival was assessed in irradiated mammalian cells upon chemical inhibition of CK2.
Methods: MRC5 human fibroblasts and WIDR human colon carcinoma cells were incubated with highly specific
CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB), or mock-treated, 2 hours prior to irradiation. DSB was measured
by pulsed-field electrophoresis (PFGE) as well as gamma-H2AX foci formation and removal. Apoptosis induction
was tested by DAPI staining and sub-G1 flow cytometry, survival was quantified by clonogenic assay.
Results: TBB treatment did not affect initial DNA fragmention (PFGE; up to 80 Gy) or foci formation (1 Gy). While
DNA fragment rejoining (PFGE) was not inhibited by the drug, TBB clearly delayed gamma-H2AX foci
disappearence during postirradiation incubation. No apoptosis induction could be detected for up to 38 hours for
both cell lines and exposure conditions (monotherapies or combination), but TBB treatment at this moderately
toxic concentration of 20 μM (about 40% survival) enhanced radiation-induced cell killing in the clonogenic assay.
Conclusions: The data imply a role of CK2 in gamma-H2AX dephosporylation, most likely through its known ability
to stimulate PP2A phosphatase, rather than DSB rejoining. The slight but definite clonogenic radiosensitization by
TBB does apparently not result from interference with an apoptosis suppression function of CK2 in these cells but
could reflect inhibitor-induced uncoupling of DNA damage response decay from break ligation.
Introduction
Protein kinase CK2 is a ubiquitous and highly conserved
protein serine/threonine kinase with a broad spectrum
of target proteins the majority of which play a role in
signal transduction and gene expression promoting cell
survival upon phosphorylation [1-3]. CK2 predominantly
exists as heteroterameric holoenzyme and, in mamma-
lian cells, basal activity of CK2 is conferred by intra-
molecular interaction of either catalytic isoform CK2a
or CK2a’ and may be regulated via the association with
ad i m e ro ft h er e g u l a t o r yC K 2 b subunit (aab2, a’a’b2,
or aa’b2) [2,4]. CK2 is dysregulated in most cancers
that have been examined with high levels found
particularly in the nuclear compartment [2,5,6]. While
the precise roles of CK2 in tumorigenesis are still not
completely understood, anti-apoptosis functions of CK2
through the regulation of tumor suppressor and onco-
gene activity have been suggested [6], and CK2 is now
considered as a potential therapeutic target [7].
Ionizing radiation-induced DNA double-strand breaks
provoke a complex cellular response which activates and
coordinates cell-cycle checkpoints, damage repair, and
the eventual onset of apoptosis [8]. The DNA damage
response (DDR) invokes chromatin structure changes
extending over megabasepair regions flanking a DSB,
particularly phosphorylations of the histone variant
H2AX [9], as well as the concomitant accumulation of
the diverse factors mediating DNA damage signaling
[10]. Their visualization by means of immunostaining
and fluorescence microscopy (the socalled “focus assay”)
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and dissecting the activating and regulatory components
of this signal amplification. CK2 targets several compo-
nents of the DDR by constitutive as well as damage
induced phosphorylations:
(i) within the major nonhomologous end joining
(NHEJ) pathway of DSB repair [11], the Xrcc4 pro-
tein, an adaptor for DNA ligase IV, was shown to
recruit DNA end-processing factors requiring CK2-
dependent constitutive phosphorylation [12]. This
implied a role for CK2 in the DSB rejoining reaction
reminiscent of CK2-dependent activation of Xrcc1 in
single-strand break repair [13].
(ii) another adaptor protein is MDC1 which, when
phosphorylated by CK2, promotes assembly and
retention of the MRE11-Rad50-Nijmegen breakage
syndrome 1 (NBS1) [MRN] complex around sites of
DSB, and in conjunction with DSB-induced ATM
(ataxia telangiectasia mutated) kinase allows spread-
ing of gH2AX formation [14-18].
(iii) a new DSB-induced function of CK2 in chroma-
tin modification was recently described due to het-
erochromatin protein 1 (HP1-b) phosphorylation
(19). HP1 is a critical factor for chromatin compac-
tion being recruited by direct interaction with
H3K9me (trimethylated lysine 9 of histone H3), an
epigenetic mark for silenced chromatin (20). It was
shown that CK2-phosphorylated HP1-b looses its
affinity for H3K9me suggesting a relieve of the struc-
tural constraints within compacted chromatin that
prevent the access of DDR factors [19,21]. Accord-
ingly, CK2 inhibition by TBB suppressed HP1-b
mobilization and diminished ATM-dependent H2AX
phosphorylation.
Less data is available on the phenotypic expression of
such CK2-dependent interactions. An increased apopto-
tic response was reported for irradiated HeLa cells when
subjected to siRNA-mediated CK2 depletion, without
affecting the radiation-induced G2-M checkpoint [22].
Other authors found an increased radiation sensitivity
due to a mutation of the CK2 consensus site in Xrcc4
both for clonogenic survival and gH2AX focus removal
but did not assess fragment rejoining [12]. With the cur-
rent study we thought to gain additional data on DSB
repair, measured with both the PFGE and the gH2AX
focus assay, apoptosis induction and clonogenic survival
after ionizing radiation exposure in response to treat-
ment with the highly specific CK2 inhibitor 4,5,6,7-tetra-
bromobenzotriazole (TBB) [23]. Experiments were
conducted with human fibroblasts and a human colon
carcinoma cell line.
Materials and methods
Cell lines and culture conditions
MRC5 (human lung fibroblasts; BioWhittacker, Verviers,
Belgium) and WIDR cells (human colon carcinoma;
Tumorbank of the German Cancer Research Center,
Heidelberg) were maintained in RPMI 1640 (MRC5) or
DMEM (WIDR) with 10% fetal calf serum (Biochrom,
Berlin, Germany) containing 1% L-glutamine (Serva,
Heidelberg, Germany). Cells were grown as monolayers
in humidified 6% CO2/air at 37°C. Under these condi-
tions cell cultures exhibited doubling times of 48 hours
(MRC5) or 28 hours (WIDR), respectively. The plating
efficiencies ranged from 70-90% for the WIDR tumor
cells and from 1-2.5% for the MRC5 fibroblasts.
Drug treatment and irradiation
Aliquots of 10 mM stock solution of the CK2 inhibitor
TBB (Calbiochem, Merck Darmstadt, Germany) in
DMSO were were stored at -20°C. For combined expo-
s u r e s ,T B Bw a sa d d e dt oc u l t u r e sa tad e s i r e dc o n c e n -
tration 2 hours prior to irradiation (also unirradiated
controls). Mock treatments were performed by adjusting
the respective DMSO concentration to that of the TBB
samples. Irrradiations of cell cultures were conducted at
a clinical linear accelerator (6 MV photon mode, 2.5
Gy/min).
Pulsed-field electrophoresis
Measurement of DSB induction and rejoining was done
by pulses-field-gel-electrophoresis (PFGE) as described,
earlier [24]. Late log-phase cells (>80% confluency) were
treated for 2 hours with 20 μMT B B( 0 , 2 %D M S O )o r
only DMSO before irradiation on ice and sample pre-
paration. Alternatively, cells were incubated for repair
prior to lysis. Data analysis involved quantification of
the fraction of total DNA mass in electrophoretically
mobile DNA fragments (FR-values) by means of ethi-
dium bromide DNA staining and a digital gel image
acquisition and analysis system (UVP Ltd., Cambridge,
UK). FR-values obtained after incubation for repair were
transformed into the respective radiation doses at which
such values had been measured without repair (“dose-
equivalents”).
Immunofluorescence
Antibodies were mouse anti-gH2AX
Ser139 (Upstate,
Buckingham, U.K.), mouse anti-CK2 (á-subunit) (Calbio-
chem, Merck KGaA, Darmstadt, Germany) and Alexa
Fluor R 488 goat anti-mouse secondary antibody (Mole-
cular Probes, Eugene, Oregon, USA). Cells grown on
coverslips were fixed (3% paraformaldehyde, 2% sucrose/
PBS for 10 min at room temperature) and permeabilized
(20 mM HEPES (pH 7.4), 50 mM NaCl, 3 mM MgCl2,
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4°C; chemicals from Sigma-Aldrich, Taufkirchen,
Germany). Coverslips were washed in PBS before immu-
nostaining. Primary antibody incubations with anti-
gH2AX or with anti-CK2a’ were performed for 40 min
at 37°C at 1:500 dilution (2 μg/ml)) in PBS supplemen-
ted with 2% bovine serum fraction V albumin (Sigma-
Aldrich) and followed by washing 4 times in PBS. Incu-
bations with fluorochrome-labelled secondary antimouse
antibodies were performed at 37°C at 1:200 dilution
(10 μg/ml) in 2% bovine serum fraction V albumin for
20 min. Nuclei were counterstained in Vectashield mount-
ing medium with DAPI (Vector Laboratories, Peterbor-
ough, United Kingdom) for 5 min at 20°C. Formation and
time-dependent disappearence of distinct gH2AX-foci was
scored in cells irradiated with 1 Gy (+/- 20 μM TBB pre-
treatment) by means of fluorescence microscopy (100×
magnification and manual focal plane scanning). Foci
present in 50 cells were counted for each sample.
Flow cytometry and apoptosis measurement
Treated cells (including a TBB treatment extended to
8 hours before irradiation) were harvested at different
times including the culture supernatant and were pre-
pared for DNA flow cytometry (FacScan/Cell-Quest Pro,
Beckton-Dickinson, Heidelberg, Germany) by propi-
dium-iodide staining, aimed at either the measurement
of cell cycle distribution or sub-G1 analysis, according
to a standardized protocol [25]. Additionally, cells
grown on microscopic slides were stained with DAPI
(4,6-diamidino-2-phenylindol) at different post-treat-
ment periods, and the nuclei were inspected for the
typical morphological appearance of chromatin conden-
sation during late apoptosis [26].
TBB-treated cells were also inspected for the phos-
phorylation status of Xrcc1 at residues S518/T519/T523,
known to be targeted by CK2 kinase [27,28], by means
of flow cytometry after intracellular immunostaining.
The respective phospho-Xrcc1 antibody (polyclonal rab-
bit anti-human IgG) was from Bethyl, Inc. (Biomol,
Berlin Germany), secondary FITC-labelled goat anti-rabbit
(Ig) was from BD Pharmingen (Heidelberg, Germany).
Rabbit IgG isotype control (Imgenex) was obtained from
Biomol. Immunostaining was performed according to the
manufactures (Bethyl) instruction.
Clonogenic assay
Clonogenicity of MRC5 and WIDR cells were measured
by a standardized colony forming assay. For combined
exposures, a fixed TBB concentration of 20 μM (0,2%
DMSO) was used. This concentration of the solute
resulted in only a small decrease of plating efficiencies
(90% to 95% relative to the plating efficiency without
DMSO for both cell lines), but samples without drug
were always mock treated. Cells were plated in triplicate
within a single experiment and at least three indepen-
dent experiments were performed for each condition
tested.
Results
CK2 was expressed in MRC and in WIDR cells as
detected by immunocytochemistry using CK2a’ antibody
and exhibited a strong preference to localize in the peri-
nuclear compartment in the tumor cells (Figure 1). The
effect of the CK2 inhibitor alone on clonogenic survival
of the MRC5 and the WIDR cells is summarized in
Figure 2. A common TBB exposure of 20 μM exhibiting
definite but still moderate toxicity was chosen for the
combination experiments. To test the inhibition of CK2
by this TBB concentration with a functional in vivo
assay, the phosphorylation status of the Xrcc1 protein at
12 hours after addition of the drug was assessed as
described, above. FACS histograms representing phos-
pho-Xrcc1 staining with or without TBB treatment are
shown in Figure 3 for MRC5 and WIDR cells. A distinct
reduction of Xrcc1 phosphorylation due to TBB is
evident.
Pulsed field electrophoresis assay
Initial radiation-induced DSB yield (20 to 80 Gy) did not
depend on 20 μM TBB pretreatment. Even for the high
exposure conditions of 200 μMv e r s u st h eD M S Oc o n -
trol treatment, the respective dose-dependencies (+/-
TBB) for the two cell lines were identical (Figure 4)
with induction rates (from fits to the random breakage
model [24,29]) of 0,0051 (MRC5) and 0,0052 (WIDR)
DSB/Mbp/Gy, respectively. DSB rejoining during incu-
bation for repair of up to 3 hours after an inducing dose
of 60 Gy (represented as dose-equivalent values, as out-
l i n e di nt h eM e t h o d ss e c t i o n )w a sa l s on o ta f f e c t e db y
20 μM TBB pretreatment of both WIDR and MRC5 cell
lines. Suspecting that the low inhibitor concentration
might have been insufficient to resolve a TBB-induced
repair defect, measurements were also done at high
exposure conditions (200 μM) within a separate set of
experiments, but rejoining was again not inhibited.
Because of the qualitative identy of the results obtained
with the two cell lines, they are exemplified for the
WIDR cells (Figure 5), only.
gH2AX focus assay
TBB-dependent (20 μM) postirradiation foci disappear-
ence (after 1 Gy) is depicted in Figure 6 for both the
MRC5 and the WIDR cells. The number of background
foci (unirradiated cells) was determined within each inde-
pendent experiment and subtracted from the respective
number of an irradiated sample. Notably, the average
number of background foci per nucleus was not different
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0.41 ± 0,15 versus 0.46 ± 0.14; WIDR: 0.6 ± 0.3 versus
0.54 ± 0.28). The data clearly demonstrates that TBB
treatment did not reduce the number of initial foci after
1 Gy although the appearence of the individual foci
was less bright (approximately reduced to 50-70%).
Subsequent foci removal, however, was markedly delayed
which is at variance with the results from the PFGE assay.
Cell vitality
Sub-G1 flow-cytometry or DAPI-staining of MRC5 or
WIDR cells failed to demonstrate apoptosis induction
Figure 1 Intracellular distribution of CK2 in MRC5 and WIDR cells as visualized by immunostaining with CK2a’ subunit antibody
(lower right panels). Lower left panels are isotype controls and the upper panels represent the respective DAPI counterstains (as indicated).
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tion, incubation with 40 μM TBB, or a combined expo-
sure even when the TBB pretreatment period was
extended to 8 hours (data not shown). Cell cycle analy-
sis by flow cytometry was able to detect the well known
radiation-induced G2-arrest (WIDR cells after 5 Gy:
Figure 7) which was clearly more expressed and prolonged
upon 20 μM TBB pretreatment. Radiation inhibition of
clonogenic survival was enhanced by the CK2 inhibition
with 20 μM TBB compared to 0.2% DMSO controls (nor-
malized data in Figure 8). For the MRC5 cells, this effect
was only observed with radiation doses ≥3G y .
Discussion
CK2 (alpha’) was expressed in both cell lines with a
marked peri-nuclear accumulation in the tumor cell
line. This finding is in accordance with the previously
reported higher ratio of nuclear to cytosolic activity of
CK2 in cancer cells than in normal cells [30]. Despite
the observed difference in basal CK2 localization, the
cytotoxic effect of CK2 inhibition was very similar with
both cell types indicating that the subcellular distribu-
tion of CK2 was not the prevailing determinant of its
pro-survival function. But this particular aspect was not
further investigated.
Figure 2 Inhibition of clonogenic survival of MRC 5 and WIDR cells by a 2 hours incubation with the CK2 inhibitor 4,5,6,7-
tetrabromobenzotriazole (TBB). Concentration of the TBB solute DMSO was adjusted to 0.7% (such as with the 70 μM TBB) for all samples.
Data points represent mean values (and standard deviations) from three independent determinations.
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(12 hours) and inspected for phospho-Xrcc1 staining (see Methods). Unstained samples are denoted as “blank”. Samples prepared from MRC5
cells (upper panel) were measured at an increased amplifier gain to allow for a better representation of the difference between the respective
histograms.
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tor is its specificity for a given target enzyme. TBB was
previously shown to exhibit a remarkable in vitro selec-
tivity for CK2 among a panel of about 80 kinases, where
only three other groups of kinases were inhibited by
TBB with comparable efficacy [23]. They are not known
to be involved in DSB processing but two of the respec-
tive kinases (HIPK2 and DYRK2) regulate p53-depen-
dent differential transactivation of growth arrest genes
versus pro-apoptotic genes in response to DNA damage
severity [31]. The reported in vitro IC50 for TBB is 0.15
μM [23] which is a factor of about 100 lower than
respective numbers obtained when cells were exposed to
TBB before protein extraction and assessment of in vitro
phosphorylation with synthetic CK2 target peptide
[32,33]. The 2 hours exposure of cells at 20 μMT B B
prior to irradiation used in the present study is therefore
considered as an effective treatment for the reduction of
CK2 activity while still being only moderately toxic in
the clonogenic assay. The efficacy of this TBB exposure
with respect to the inhibition of CK2 was further con-
firmed by a functional assay (Figure 3) that measured
intracellular phosphorylation of a protein (Xrcc1) for
which CK2 is known to be the major kinase [27,28].
The major result of the present investigation, however,
is the discrepancy between DSB rejoining (PFGE) and
the disappearence of gH2AX foci, where only the latter
was delayed upon CK2 inhibition. A comparison of the
results obtained with these two methods needs to con-
sider the widely different doses applied. Analysis of
DNA fragmentation requires sufficiently small fragments
that may be resolved during electrophoresis and which
are only produced at high doses. On the contrary, the
focus assay is applicable at doses of only a few Gy. A
comparison of absolute repair/rejoining rates derived
with these different assay may thus be problematic. But
particularly with the PFGE assay, it is not known that a
repair modification, by whatever reason, would become
differentially detectable depending on the dose level at
which it is investigated.
Therefore, CK2-phosphorylated factors known to be
involved in the response to radiation-induced DSB
(Xrcc4, MDC1 or HP1-b; referred to in the Introduction
section) need to be discussed.
Xrcc4 is constitutively phosphorylated at Thr233 by
CK2 and this was shown to mediate the recruitment of
DSB end-processing factors [12] which aid NHEJ [11].
Utilizing a Thr233 mutant system, it was also shown
that lack of the CK2-targeted site resulted in a delayed
removal of gH2Ax foci, but an actual rejoining defect,
which may well have existed, was not assessed by these
authors [12]. One has to keep in mind that the absence
of constitutive CK2-dependent Xrcc4 phosphorylation
represents a quite different situation compared to the
Figure 4 Pulsed-field electrophoresis (PFGE) measurement of ionizing radiation-induced DNA double-strand breakage in MRC5 and
WIDR cells (as indicated in the graphs). Fractions of electrophoretically mobile DNA (fragments < 9 Mbp), or FR-value, increases with dose
according to the random breakage formalism (solid lines). DSB induction is not affected by TBB pretretment (200 μM for two hours) compared
to the respective 2% DMSO controls. Data points represent mean values (and standard deviations) from three independent experiments.
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irradiation and assessment of DSB rejoining. Therefore,
the phosphorylation status of Xrcc4 (at the CK2 residue)
is sufficiently long-lived, or does not impact on NHEJ
efficiency to an extent that could be resolved by our
PFGE assay.
MDC1 is constitutively phosphorylated at multiple resi-
dues by CK2 [15]. But unlike Xrcc4, MDC1 functions -
via MRN-complex recruitment - in the propagation and
retention of the chromatin changes that spread over large
regions surrounding a DSB, particularly the ATM-depen-
dent H2AX phosphorylation (see: Introduction section),
rather than being involved in the DSB rejoining reaction
[11,15]. The present experiments could not detect an
inhibitory effect of TBB on the number of initially formed
gH2AX foci. This is in accordance with an earlier obser-
vation where TBB was unable to abrogate MRN recruit-
ment (NBS1 foci) whereas downregulation of CK2 by
siRNA was effective, leading to the conclusion that che-
mical CK2 inhibition was not potent enough to suffi-
ciently reduce CK2 activity towards MDC1 [15].
Recently, ATM was shown to act as a repair factor for
DSB in heterochromatic regions of the genome by phos-
phorylating heterochromatin protein KAP-1 to allow for
Figure 5 Residual DNA fragmentation (represented as dose-equivalent values, see Methods section) after different periods of
incubation for repair of WIDR cells in the presence of 20 μM TBB or 200 μM TBB (as indicated) added for 2 hours prior to irradiation
with 60 Gy. Data points represent mean values (and standard deviations) from three independent determinations.
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tion that would otherwise inhibit repair [34-36]. Nota-
bly, knockdown of another heterochromatin protein,
HP1-b, relieved the requirement for ATM in hetero-
chromatic DSB repair [34,35]. HP1-b is phosphorylated
by CK2 in response to DNA damage leading to its
mobilization from chromatin and allowance for H2AX
phosphorylation [19]. Accordingly, CK2 inhibition by
20 μM TBB resulted in a decreased fluorescence inten-
sity of the individual gH2AX foci formed shortly after
irradiation, which is at least qualitatively confirmed by
our observation. Whether a TBB treatment affected DSB
rejoining was not measured by these authors [19], but
our results strongly argue against this possibility.
Because foci did in fact form with initial numbers being
independent from TBB preexposure, we conclude that
the role of CK2 in the DNA damage response is to aid
the propagation of chromatin changes, i.e. by the sug-
gested mobilization of HP1, distal to the DSB site rather
than being involved in initial damage recognition and
rejoing. This appears to be different to the role of ATM
in heterochromatin repair, where cells with defective or
downregulated ATM fail to rejoin that particular por-
tion (about 15%) of all induced DSB [37].
These considerations, however, do not answer the
question why the disappearance of foci was delayed due
to CK2 inhibition. gH2AX focus decay may proceed
through in-situ dephosphorylation or by histone
exchange (followed by dephosphorylation of displaced
gH2AX). In mammalian cells, protein phosphatase PP2A
seems to be crucially involved in gH2AX dephosphoryla-
tion [38]. It was shown that PP2A directly interacts with
CK2 catalytic subunit a kinase thus getting phospory-
lated and activated [39] implicating a role of CK2 in
gH2AX turnover. The respective scheduling, however, is
still controversial. The early decrease in the number of
foci was not associated with a significant change in the
global gH2AX level as measured by flow cytometry or
western blotting [40] favouring the idea of a histone
exchange mechanism being responsible for the dissolu-
tion of foci which would then not a priori require phos-
phatase activity. A similar conclusion was reached when
the inhibition of PP2A by calyculin A, an agent known
to suppress gH2AX dephosporylation [41], had only a
small effect on foci eliminati o n[ 4 2 ] .I nc o n t r a s t ,o t h e r
authors did in fact observe a strong inhibition of foci
decay by PP2A inhibitor calyculin A following radiation
exposure (10, 42). Notably, this finding was not accom-
panied by a respective rejoining defect (using PFGE ana-
lysis) similar to what is found in the present
investigation. A slower removal of gH2AX foci was also
noted when a more specific inhibitor of PP2A (fostrie-
cin) was used, or when employing PP2A catalytic subu-
nit knockdown [38]. In the latter study, foci formation
was induced by stalling replication forks due to treat-
ment with topoisomerase inhibitor camptothecin and,
contrary to the radiation studies [10,43], a concurrently
expressed repair defect was measured by means of neu-
tral comet assay. Whether this discrepancy could relate
to the different mechanisms of damage induction or the
distinct experimental approaches to assess residual
breakage remains unclear.
Figure 6 Average number of gH2AX foci in the nuclei of MRC5
cells (upper panel) or WIDR cells (lower panel) after different
periods of incubation for repair and in the presence of 20 μM
TBB added for 2 hours prior to irradiation with 1 Gy.
Background numbers of foci were subtracted within each individual
experiment (50 nuclei per treatment condition) before calculating
the displayed mean values (and standard deviations) from at least 4
independent determinations.
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tions argue for an involvement of CK2 in DNA damage
response relaxation through its ability to stimulate
in-situ gH2AX dephosphorylation, most likely via PP2A
recruitment/activation. Because foci decay is thought to
reflect a timely response to finalized damage repair, CK2
appears to exert a respective coordinating function
which can be uncoupled upon its chemical inhibition
whereby the end joining reaction is not affected (at least
under the experimental conditions, used here). The
Figure 7 Cell cycle measurements (FACS) at different times after 5 Gy irradiation of WIDR cells pretreated (2 hours) with 20 μMT B B
(lower panels) or DMSO, only (middle panels). The upper panels show histograms after TBB treatment without irradiation which were
identical to the respective DMSO controls (not shown).
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checkpoint function at the G2/M border when CK2 was
inhibited (as demonstrated for the WIDR cells in Figure 7)
would be consistent with this idea.
The slight, though definitive, increase of clonogenic
radiosensitivity of both cell lines when CK2 was inhib-
ited could thus relate to an imbalanced DNA damage
response. Different from an earlier study using HeLa
tumor cells with CK2 being depleted by means of RNA
interference [22], this effect was not due to triggering
apoptosis which could potentially result from persistant
damage signaling. Accordingly, the present observations
reflect the modification of other major mechanisms
through which clonogenicity upon irradiation is abro-
gated, i.e. a permanent growth arrest such as expressed
in non-transformed fibroblasts or the prevailing mitotic
catastrophe when cells bearing residual DNA damage
enter mitosis [44]. While a persistant damage signaling
could in fact enhance permanent growth arrest (such as
in the fibroblasts), it is not immediately clear how a pro-
longation of the radiation-induced G2/M transition delay
(at undisturbed repair efficacy) would potentiate mitotic
failures. CK2 has been implicated in the efficacy of either
checkpoint by interactions with other key regulatory ele-
ments including the tumor suppressor p53 [45,46] or the
phosphatase cdc25B and C isoforms [47,48]. But given
the highly promiscious nature of CK2, other coordinating
factors of cell cycle progression after DNA damage (i.e.
SMC3 for intra-S phase checkpoint [49]) may have been
affected by the TBB treatment, as well. The phenotypes
of increased radiation sensitivities of the two cell systems
may thus reflect distinct and differentially CK2-depen-
dent factors of the DNA damage response. This could
tentatively explain the intriguing qualitative difference in
the dose-dependence of TBB-induced radiosensitization
where the fibroblasts but not the tumor cells exhibited a
significant threshold-type behaviour. Whether this differ-
ence is maintained when high radiation doses are deliv-
ered by small consecutive doses in a fractionation
schedule is presently under investigation. In the absence
of more pronounced differentially expressed phenotypes
in tumor cells versus normal cells, however, a potential
therapeutic benefit of a TBB-radiation combination can
presently not be implied.
Conclusion
T h ed a t ai m p l yar o l eo fC K 2i ngH2AX dephosporyla-
tion, most likely through its known ability to stimulate
PP2A phosphatase, while DSB physical rejoining was
unaffected. The slight but definite enhanced clonogenic
radiation response by TBB does apparently not result
from interference with an apoptosis suppression func-
tion of CK2 in these cells but could reflect inhibitor-
induced uncoupling of DNA damage response decay
from break ligation.
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